Posted: June 24, 2020
Gideon Blumenthal, MD, has transitioned from Deputy Director of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA) to Vice President of Global Regulatory Affairs for Oncology at Merck. Dr. Blumenthal was with the FDA for more than a decade, after more than 12 years of service at the National Cancer Institute.
